Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: filgrastim|DRUG: capecitabine|DRUG: celecoxib|DRUG: cyclophosphamide|DRUG: docetaxel|DRUG: doxorubicin hydrochloride|GENETIC: gene expression analysis|GENETIC: polymorphism analysis|GENETIC: protein expression analysis|GENETIC: reverse transcriptase-polymerase chain reaction|OTHER: imaging biomarker analysis|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis|OTHER: pharmacogenomic studies|PROCEDURE: dynamic contrast-enhanced magnetic resonance imaging|PROCEDURE: needle biopsy|PROCEDURE: neoadjuvant therapy|PROCEDURE: radiomammography|PROCEDURE: ultrasound imaging
Sponsor: University of Nebraska
Collaborators: National Cancer Institute (NCI)